News

UAB researchers have identified a new communication pathway in which extracellular vesicles from T cells influence neural activity and improve social behavior, offering insights into mental health disorders.

UAB expert provides professional insight on daycare illnesses and tips on how to reduce the spread of germs. 

A UAB researcher says resilience to warming temperatures starts at the smallest scale. 

UAB researchers developed a novel RNA-based molecular test that more accurately distinguishes active C. diff infection from colonization, improving diagnosis of hospital-acquired illness and helping reduce missed cases and unnecessary antibiotic treatment.

Though radiologists work almost entirely behind the scenes, their interpretations guide countless clinical decisions and influence almost every patient’s care journey. 

UAB sports medicine and nutrition experts are sharing guidance on injury-prevention, safe conditioning, hydration and nutrition to support performance and well-being.

This year, City of Birmingham Mayor Randall Woodfin joined employees at UAB and Children’s of Alabama to celebrate the five-year anniversary of the NICU Bookworms program and recognize all that has been accomplished since its establishment.

Why do some people suddenly feel old? A UAB aging expert explains the biological and lifestyle factors behind aging, common triggers such as stress and illness, and practical strategies to maintain strength, resilience, independence and quality of life.

Researchers at UAB and Cincinnati Children’s Hospital Medical Center have uncovered that supplemental indigo light may effectively reduce the progression of myopia.

UAB startup NuVasc is advancing precision medicine for brain arteriovenous malformations with a novel liquid biopsy that identifies genetic mutations driving AVMs, paving the way for targeted therapies and improved patient outcomes.

UAB researchers are investigating the origin recognition complex, a key component of DNA replication, to better understand how cancer develops and identify potential new targets for treatment.

Within the past three years, four pivotal clinical trials co-led by UAB’s Dana Rizk, M.D., have completely changed the treatment landscape for IgA nephropathy. “Many of the patients who took part in the trials here had tried and failed many other treatments,” Rizk said. “To know that they now have these new drugs available to them is remarkable.”